INHIBIKASE THERAPEUTIC
1.2500
07-十月-24 15:59:55
15 分钟延时
股票
-0.0100
-0.79%
今日范围
1.2000 - 1.3100
ISIN
N/A
来源
NASDAQ
-
14 8月 2024 16:25:26 条件 Nasdaq GlobeNewswire
-
Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
07 8月 2024 08:00:08 条件 Nasdaq GlobeNewswire
-
17 6月 2024 08:05:00 条件 Nasdaq GlobeNewswire
-
05 6月 2024 08:05:00 条件 Nasdaq GlobeNewswire
-
20 5月 2024 08:01:00 条件 Nasdaq GlobeNewswire
-
15 5月 2024 20:00:00 条件 Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Announces Request for Withdrawal of S-1 Registration Statement
15 5月 2024 08:45:00 条件 Nasdaq GlobeNewswire
-
09 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
18 4月 2024 16:30:00 条件 Nasdaq GlobeNewswire
-
03 4月 2024 08:05:00 条件 Nasdaq GlobeNewswire
-
27 3月 2024 16:15:20 条件 Nasdaq GlobeNewswire
-
07 3月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro
28 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
07 2月 2024 07:55:00 条件 Nasdaq GlobeNewswire
-
29 1月 2024 09:05:00 条件 Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli
16 1月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
19 12月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
Inhibikase Therapeutics Granted Pre-NDA Meeting with the FDA for IkT-001Pro
04 12月 2023 08:35:00 条件 Nasdaq GlobeNewswire
-
14 11月 2023 16:30:06 条件 Nasdaq GlobeNewswire
-
07 11月 2023 09:28:32 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >